ArticleCancers2019
Rationale for a Combination Therapy Consisting of MCL1- and MEK-Inhibitors in Acute Myeloid Leukemia.
Katja Seipel et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
14 papers cite it
this papercites it
ArticleCancers2019
Katja Seipel et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.